The article discusses lawsuits against Abbott and Mead Johnson, two major manufacturers of specialized infant formulas designed for premature babies. Parents of infants who suffered from necrotizing enterocolitis (NEC), a severe intestinal condition affecting preemies, have filed numerous lawsuits alleging that the use of these formulas caused or contributed to their children's illnesses.
Key points include:
- The companies are heavily involved in litigation regarding the safety and efficacy of their products for premature infants.
- Lawsuits claim that specialized infant formulas designed for preterm babies can cause NEC when used improperly.
- Abbott and Mead Johnson deny responsibility, arguing there is no conclusive scientific evidence linking their products to NEC.
- The companies emphasize competition between each other rather than promoting formula over human milk.
- Court cases have resulted in large judgments against the manufacturers while others are still pending.
The article highlights the tension between the companies' marketing and sales strategies focused on "winning" hospital contracts, and legal claims that their products may be harmful when used improperly for extremely premature infants. It also notes ongoing medical debate about NEC's causes and whether specialized formulas contribute to its occurrence in some cases.
Read the full article at KFF Health News
Want to create content about this topic? Use Nemati AI tools to generate articles, social posts, and more.
![[AINews] The Unreasonable Effectiveness of Closing the Loop](/_next/image?url=https%3A%2F%2Fmedia.nemati.ai%2Fmedia%2Fblog%2Fimages%2Farticles%2F600e22851bc7453b.webp&w=3840&q=75)
